Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ProtoKinetix, a biotechnology company, has entered into a collaborative research agreement with a global multi-billion dollar company that provides products and services to pharmaceutical and biotechnology companies, as well as academic and research institutions.
Subscribe to our email newsletter
This company is recognized worldwide as one of the innovators of cell and tissue engineering. Due to the sensitivity and competitive nature of this industry, the company has requested that, at this time, its name be kept confidential.
ProtoKinetix has a patented family of anti-aging glycopeptides (AAGP) that have clearly demonstrated a superior ability to protect cells and tissues subjected to hostile conditions. This collaboration will provide a platform to develop cell preservation formulations for specific applications of AAGP in a wide range of cell and tissue therapies.